However, demand in 2022 still held above pre-pandemic ranges and y-o-y comparisons are against the very robust volumes of 2021. The solid US jobs market was a supportive factor, while Christmas gifting helped carry Q4 demand. Vikas Khemani of Carnelian Capital Advisors discusses the growth potential of the pharma sector and the optimistic outlook for IT companies like TCS and Infosys.
- Our contacts suggested that demand came to a virtual standstill after mid-December, with prospects preferring gold-for-gold trade; anecdotal proof suggests such change volumes virtually doubled in the course of the quarter.
- Titan Company on Friday reported a nearly 10%